Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Armata Pharmaceuticals, Inc. (ARMP) had Return on Tangible Equity of 11.40% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.49M |
|
$-6.53M |
|
-- |
|
$0.49M |
|
$8.68M |
|
$-8.19M |
|
$1.66M |
|
$-6.53M |
|
$-6.53M |
|
$-6.53M |
|
$-6.53M |
|
$-6.53M |
|
$-6.53M |
|
$-8.19M |
|
$-7.81M |
|
36.19M |
|
59.48M |
|
$-0.18 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$13.17M |
|
$12.88M |
|
$74.08M |
|
$87.25M |
|
$110.54M |
|
-- |
|
$30.49M |
|
$141.03M |
|
$-53.78M |
|
$-57.27M |
|
$-53.78M |
|
36.19M |
|
| Cash Flow Statement Financials | |
$-7.58M |
|
$-0.10M |
|
$9.99M |
|
$14.77M |
|
$17.08M |
|
$2.31M |
|
$0.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-- |
|
-1.91 |
|
100.00% |
|
-1668.23% |
|
-1668.23% |
|
-- |
|
-1330.14% |
|
-1330.14% |
|
$-7.68M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
2.06 |
|
43.63 |
|
12.14% |
|
|
Return on Tangible Equity |
11.40% |
-7.49% |
|
12.14% |
|
$-1.49 |
|
$-0.13 |
|
$-0.13 |
|